SPECIFICITY IN ENDOTHELIAL CELL CALCIUM SIGNALING

内皮细胞钙信号转导的特异性

基本信息

  • 批准号:
    6499015
  • 负责人:
  • 金额:
    $ 18.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-02-01 至 2004-01-31
  • 项目状态:
    已结题

项目摘要

Specificity in Endothelial Cell Calcium Signaling. The endothelial receives and integrates a variety of stimuli related to blood flow control (i.e. shear stress and vasoactive mediators), inflammation, and growth/repair. Inappropriate or defective endothelial cell responses to these stimuli can lead to a variety of vascular pathologies. Transduction of signals from all of these stimuli relies, in part, on mobilization of intracellular calcium. In large vessel endothelial cells, intracellular calcium pools are managed by two sarco (endothelial cell) plasmic calcium ATPases (SERCA); the uniquely expressed SERCA3 and the ubiquitous SERCA2b pumps. Mice lacking SERCA3 (SERCA3 knockout) are born viable with intact vasculature. However, aortas from these mice fail to respond to the vasodilator acetylcholine. Furthermore, SERCA3-deficient aortic endothelial cells do not generate a calcium transient in response to acetylcholine. The defects in endothelial cell activity present in the SERCA3 knockout mouse occur even though SERCA2b is present. These observations have lead to the hypothesis that endothelial cells utilize distinct intracellular calcium pools, as defined by these two SERCA pumps, to mediate responses to different types of stimuli. The goal of this project is to test this hypothesis, through completion of four specific aims, by demonstrating that the calcium pool maintained by SERCA3 participates in a subset of endothelial cell responses and that this calcium pool is segregated from the SERCA2b-managed pool within the endothelial cell. Specific aims 1 and 2 will characterize the distribution and the spatial organization of the SERCA3- and SERCA2b- managed calcium in the generation of calcium transients and endothelial cell responses induced by four classes of vascular stimuli (shear stress, vasoactivity, inflammation, and vascular repair) in endothelial cells from these mice will provide the experimental basis for these studies. Selective differences observed between cells and vessels of the two mice can be attributed to the absence of calcium stores established by SERCA3 and indicate those processes relying on this calcium pool. Completion of these aims will provide further insight into how specificity in calcium-mediated endothelial cell signal transduction is established and thus provide possible avenues for specific therapies directed at treating vascular disease.
内皮细胞钙信号的特异性。内皮细胞接受并整合与血流控制(即剪切应力和血管活性介质)、炎症和生长/修复相关的各种刺激。内皮细胞对这些刺激的反应不适当或有缺陷可导致各种血管病变。所有这些刺激信号的转导部分依赖于细胞内钙的动员。在大血管内皮细胞中,细胞内钙池由两个sarco(内皮细胞)质钙atp酶(SERCA)管理;独特表达的SERCA3和普遍存在的SERCA2b泵。缺乏SERCA3 (SERCA3敲除)的小鼠出生时具有完整的血管系统。然而,这些小鼠的主动脉对血管扩张剂乙酰胆碱没有反应。此外,serca3缺陷的主动脉内皮细胞在乙酰胆碱作用下不会产生钙瞬态反应。即使SERCA2b存在,在SERCA3敲除小鼠中存在的内皮细胞活性缺陷也会发生。这些观察结果导致假设内皮细胞利用不同的细胞内钙池,如这两个SERCA泵所定义的,来介导对不同类型刺激的反应。该项目的目标是通过完成四个特定目标来验证这一假设,通过证明SERCA3维持的钙池参与内皮细胞反应的一个子集,并且该钙池与内皮细胞内serca2b管理的钙池分离。具体目标1和2将描述SERCA3-和SERCA2b-管理的钙在这些小鼠内皮细胞中钙瞬变的产生和四类血管刺激(剪切应力、血管活性、炎症和血管修复)诱导的内皮细胞反应中的分布和空间组织,为这些研究提供实验基础。在两种小鼠的细胞和血管之间观察到的选择性差异可归因于缺乏由SERCA3建立的钙储存,并表明这些过程依赖于这种钙池。这些目标的完成将进一步深入了解钙介导的内皮细胞信号转导的特异性是如何建立的,从而为针对血管疾病的特异性治疗提供可能的途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES B HOYING其他文献

JAMES B HOYING的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES B HOYING', 18)}}的其他基金

human Microvessel Culture System (hMCS)
人类微血管培养系统 (hMCS)
  • 批准号:
    8521734
  • 财政年份:
    2013
  • 资助金额:
    $ 18.65万
  • 项目类别:
Fabricated Microvascular Networks
制造微血管网络
  • 批准号:
    7822693
  • 财政年份:
    2007
  • 资助金额:
    $ 18.65万
  • 项目类别:
Fabricated Microvascular Networks
制造微血管网络
  • 批准号:
    7522736
  • 财政年份:
    2007
  • 资助金额:
    $ 18.65万
  • 项目类别:
Fabricated Microvascular Networks
制造微血管网络
  • 批准号:
    7615643
  • 财政年份:
    2007
  • 资助金额:
    $ 18.65万
  • 项目类别:
Fabricated Microvascular Networks
制造微血管网络
  • 批准号:
    7463922
  • 财政年份:
    2007
  • 资助金额:
    $ 18.65万
  • 项目类别:
Sarco(endo)plasmic Reticulum Calcium ATPse 3
肌(内)质网钙 ATPse 3
  • 批准号:
    6884617
  • 财政年份:
    2001
  • 资助金额:
    $ 18.65万
  • 项目类别:
Sarco(endo)plasmic Reticulum Calcium ATPse 3
肌(内)质网钙 ATPse 3
  • 批准号:
    6537957
  • 财政年份:
    2001
  • 资助金额:
    $ 18.65万
  • 项目类别:
Sarco(endo)plasmic Reticulum Calcium ATPse 3
肌(内)质网钙 ATPse 3
  • 批准号:
    6638742
  • 财政年份:
    2001
  • 资助金额:
    $ 18.65万
  • 项目类别:
Sarco(endo)plasmic Reticulum Calcium ATPse 3
肌(内)质网钙 ATPse 3
  • 批准号:
    6725495
  • 财政年份:
    2001
  • 资助金额:
    $ 18.65万
  • 项目类别:
Sarco(endo)plasmic Reticulum Calcium ATPse 3
肌(内)质网钙 ATPse 3
  • 批准号:
    6319117
  • 财政年份:
    2001
  • 资助金额:
    $ 18.65万
  • 项目类别:

相似海外基金

Control of calcium flux and mitochondrial fission by the Charcot Marie Tooth disease protein Mfn2.
腓骨肌萎缩症蛋白 Mfn2 对钙通量和线粒体裂变的控制。
  • 批准号:
    10322143
  • 财政年份:
    2021
  • 资助金额:
    $ 18.65万
  • 项目类别:
Control of calcium flux and mitochondrial fission by the Charcot Marie Tooth disease protein Mfn2.
腓骨肌萎缩症蛋白 Mfn2 对钙通量和线粒体裂变的控制。
  • 批准号:
    10154169
  • 财政年份:
    2021
  • 资助金额:
    $ 18.65万
  • 项目类别:
Control of calcium flux and mitochondrial fission by the Charcot Marie Tooth disease protein Mfn2.
腓骨肌萎缩症蛋白 Mfn2 对钙通量和线粒体裂变的控制。
  • 批准号:
    10540812
  • 财政年份:
    2021
  • 资助金额:
    $ 18.65万
  • 项目类别:
Purinergic control of calcium flux in podocytes
足细胞钙流的嘌呤能控制
  • 批准号:
    9552989
  • 财政年份:
    2018
  • 资助金额:
    $ 18.65万
  • 项目类别:
Purinergic control of calcium flux in podocytes
足细胞钙流的嘌呤能控制
  • 批准号:
    10292941
  • 财政年份:
    2018
  • 资助金额:
    $ 18.65万
  • 项目类别:
Purinergic control of calcium flux in podocytes
足细胞钙流的嘌呤能控制
  • 批准号:
    10047722
  • 财政年份:
    2018
  • 资助金额:
    $ 18.65万
  • 项目类别:
Boron accelerates cultured osteoblastic cell activity through calcium flux
硼通过钙流加速培养的成骨细胞活性
  • 批准号:
    25670812
  • 财政年份:
    2013
  • 资助金额:
    $ 18.65万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Claudin 12 mediates paracellular calcium flux between opossum kidney cell monolayers
Claudin 12 介导负鼠肾细胞单层之间的细胞旁钙通量
  • 批准号:
    240882
  • 财政年份:
    2011
  • 资助金额:
    $ 18.65万
  • 项目类别:
Molecules & Mechanisms Mediating Proximal Tubular Calcium Flux
分子
  • 批准号:
    244633
  • 财政年份:
    2011
  • 资助金额:
    $ 18.65万
  • 项目类别:
    Salary Programs
Mercury induced disruptions of cellular calcium flux in paired neurons from lymnaea affect synaptic transmission and elicit apoptosis
汞诱导的成对神经元中细胞钙通量的破坏影响突触传递并引发细胞凋亡
  • 批准号:
    348881-2007
  • 财政年份:
    2007
  • 资助金额:
    $ 18.65万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了